Hospital
James Lawrence Kernan Hospital, INC.
James Lawrence Kernan Hospital, INC. was paid $5.90M by Medicaid between Jan 2018 and Nov 2024, across 22 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 91% of everything it billed.
33Billing provider infoJAMES LAWRENCE KERNAN HOSPITAL, INC.
BALTIMORE, MD 21207
BALTIMORE, MD 21207
33aNPI1841337805assigned 01/31/2007
33bProvider typeRehabilitation Hospital Unit
28Total paid$5.90M
24GClaims19,321
24DCodes billed22
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Rehabilitation Hospital Unit providers in Maryland
Rank by total paid#2 of 5
Median peer was paid$4.53M
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,213 | $2.97M | |
| 2019 | 3,681 | $2.48M | |
| 2020 | 1,410 | $66K | |
| 2021 | 2,190 | $85K | |
| 2022 | 2,165 | $83K | |
| 2023 | 3,471 | $137K | |
| 2024incomplete | 2,191 | $74K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 91% | 1,446 | 1,379 | $5.35M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 6.3% | 7,765 | 6,983 | $370K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.4% | 5,480 | 1,450 | $83K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,449 | 574 | $41K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 869 | 840 | $33K |
| 20610 | <1% | 29 | 12 | $6K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 93 | 93 | $6K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 517 | 237 | $4K |
| 97116 | <1% | 419 | 143 | $3K | |
| 76000 | <1% | 88 | 86 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 210 | 206 | $746.58 |
| 62370 | <1% | 14 | 14 | $237.80 |
10 more codes
| 97542 | <1% | 54 | $44.09 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 72 | $15.07 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 31 | $1.04 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 270 | $0.15 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 235 | $0.13 |
| 80306 | 0% | 49 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 19 | $0.00 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 0% | 176 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 22 | $0.00 |
| 97166 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOGIN, MARINA (CFO)
| Provider | Location | Paid |
|---|---|---|
| Kernan Dentistry | Baltimore, MD | $3.51M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.